| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 25 Apr 2025 | 17 Apr 2025 |
| Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2025 inter alia to consider and approve 1. Audited Financial Statements and Financial Results (Standalone and Consolidated) of the Company for the Quarter and Financial Year ended March 31 2025. 2. recommend payment of Final Dividend if any for the Financial Year ended March 31 2025. Outcome of Board Meeting held on April 25, 2025. (As Per BSE Announcement Dated on: 25/04/2025) | ||
| Board Meeting | 21 Jan 2025 | 13 Jan 2025 |
| Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2025 ,inter alia, to consider and approve Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31, 2024 Outcome of Board Meeting held on January 21, 2025. Allotment of 7500 Equity shares under Rossari Employee Stock Option Plan -2019. (As Per Bse Announcement Dated on 21.01.2025) | ||
| Board Meeting | 30 Nov 2024 | 30 Nov 2024 |
| The Board of Directors have inter alia approved Incorporation of wholly owned subsidiary in Kingdom of Saudi Arabia and other matters. | ||
| Board Meeting | 19 Oct 2024 | 11 Oct 2024 |
| Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/10/2024 inter alia to consider and approve Unaudited Financial Results (Standalone And Consolidated) For the quarter and half year ended September 30 2024 Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2024 - (Readable) (As per BSE Announcement Dated on 19/10/2024) | ||
| Board Meeting | 20 Jul 2024 | 12 Jul 2024 |
| Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/07/2024 inter alia to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2024 The Board of Directors have inter alia approved the Unaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2024. (As Per BSE Announcement dated on 20.07.2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
